KRAS and lung cancer: In a prior study, we found that MTH1 suppression similarly affected KRASV12 expression, oncogenic ROS and tumorigenicity in established p53 null or-nonfunctional KRAS-driven lung cancer cells despite an absence of increased DNA strand breaks [5].